EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
63.50
-1.00 (-1.55%)
At close: Aug 10, 2026
EQUINOX NEPREMICNINE d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 8.78 | 8.69 | 7.63 | 7.15 | 6.51 | 5.98 |
Other Revenue | 0.76 | 0.69 | 1.04 | 0.63 | 0.84 | 0.73 |
| 9.54 | 9.37 | 8.67 | 7.79 | 7.34 | 6.71 | |
Revenue Growth (YoY | -1.76% | 8.10% | 11.35% | 6.03% | 9.38% | - |
Property Expenses | 1.79 | 1.69 | 2.1 | 1.62 | 2.42 | 2.08 |
Depreciation & Amortization | 3.64 | 3.81 | 3.93 | 3.76 | 3.41 | 3.43 |
Other Operating Expenses | 0.9 | 1.51 | 2.33 | 2.04 | 0.11 | 0.76 |
Total Operating Expenses | 6.33 | 7.01 | 8.36 | 7.42 | 5.94 | 6.27 |
Operating Income | 3.22 | 2.36 | 0.31 | 0.37 | 1.4 | 0.45 |
Interest Expense | -0.44 | -0.45 | -0.51 | -0.64 | -0.85 | -0.33 |
Interest & Investment Income | 0.99 | 1.34 | 1.58 | 1.24 | 0.3 | 0.19 |
Other Non-Operating Income | -0 | -0 | 0 | 0 | 0 | 0.07 |
EBT Excluding Unusual Items | 3.76 | 3.25 | 1.38 | 0.97 | 0.85 | 0.38 |
Asset Writedown | 0.01 | 0.01 | 0 | - | - | - |
Pretax Income | 3.77 | 3.26 | 1.38 | 0.97 | 0.85 | 0.38 |
Income Tax Expense | 0.94 | 0.88 | 0.31 | 0.1 | 0.14 | -0.16 |
Net Income | 2.83 | 2.38 | 1.07 | 0.87 | 0.71 | 0.54 |
Net Income to Common | 2.83 | 2.38 | 1.07 | 0.87 | 0.71 | 0.54 |
Net Income Growth | 118.07% | 122.71% | 23.11% | 22.07% | 31.87% | - |
Basic Shares Outstanding | 2 | 2 | 2 | 2 | 2 | - |
Diluted Shares Outstanding | 2 | 2 | 2 | 2 | 2 | - |
Shares Change | -0.78% | 0.09% | -1.51% | 1.73% | - | - |
EPS (Basic) | 1.59 | 1.34 | 0.60 | 0.48 | 0.40 | - |
EPS (Diluted) | 1.59 | 1.34 | 0.60 | 0.48 | 0.40 | - |
EPS Growth | 119.77% | 122.50% | 25.00% | 20.00% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 2.000 | 2.000 | 1.830 | 1.690 | 1.430 | - |
Dividend Growth | 9.29% | 9.29% | 8.28% | 18.18% | - | - |
Operating Margin | 33.70% | 25.20% | 3.60% | 4.72% | 19.11% | 6.68% |
Profit Margin | 29.67% | 25.42% | 12.34% | 11.16% | 9.70% | 8.04% |
EBITDA | 8.59 | 6.17 | 4.25 | 4.13 | 4.81 | 3.88 |
EBITDA Margin | 90.00% | 65.85% | 48.96% | 53.05% | 65.54% | 57.83% |
D&A For Ebitda | 5.37 | 3.81 | 3.93 | 3.76 | 3.41 | 3.43 |
EBIT | 3.22 | 2.36 | 0.31 | 0.37 | 1.4 | 0.45 |
EBIT Margin | 33.70% | 25.20% | 3.60% | 4.72% | 19.11% | 6.68% |
Effective Tax Rate | 24.85% | 26.90% | 22.30% | 10.49% | 16.20% | - |
Revenue as Reported | 9.54 | 9.37 | 8.67 | 7.79 | 7.34 | - |